Articles by: Geisel Communications

When Do You Need to Start Getting a Mammogram? New Research Says Starting at 40 Can Save Lives. – Yahoo! Life

Read article – Debra Monticciolo, a professor of radiology, is featured in an article about her study into breast cancer screening. “It comes down to valuing women’s lives,” Monticciolo said. “I am hoping that primary care physicians see that the risks of screening are manageable, and the benefits are tremendous. We need to do this for women.”

Match Day 2024 Livestream

Match Day 2024 Livestream

We will be streaming live video of our annual Match Day event so that friends, family, and colleagues can join in the excitement. Tune in here on Friday, March 15 at 11:30am EST, to watch live video of Geisel’s 2024 Match Day event.

Annual Mammograms Starting at 40 Saves Most Lives – HealthDay News

Read article – Debra Monticciolo, a professor of radiology, is featured in an article about her research into the benefits of screening for breast cancer from the age of 40. “The biggest takeaway point of our study is that annual screening beginning at 40 and continuing to at least age 79 gives … the most cancer deaths averted, and the most years of life gained,” Monticciolo said. (Picked up by U.S. News & World Report, Medical Xpress, VTCNG.)

‘Unprecedented’ Results for CAR-T Cells in Lupus May Signify New Era in Treatment – Healio

Read article – William Rigby, a professor of medicine and of microbiology and immunology, is featured in an article about the success of Chimeric antigen receptor T-cell therapy in lupus. “It may be the newest, greatest thing since sliced bread. It looks awfully good. But there is a very limited number of patients who have been in trials,” Rigby said.

Do Antibodies Help Vaccines Protect Against Herpes – Precision Vaccinations

Read article – David Leib, chair and a professor of microbiology and immunology, is featured in an article about his Geisel School of Medicine study in collaboration with Thayer School of Engineering into the role of antibodies in fighting herpes simplex virus infections. “Despite three decades of trying, the scientific community has been unable to develop an effective vaccine against herpes, and I think the main issue has been that we haven’t fully understood what we need, in terms of antibodies and their specific functions, to protect against this disease,” Leib said.

Developing an Effective Vaccine for Herpes Simplex Virus – Drug Target Review

Read article – David Leib, chair and a professor of microbiology and immunology; Margaret Ackerman, a professor of engineering; Matthew Slein, Guarini; and Iara Backes, Guarini ’22, MED ’24, are featured in an article about their study into how antibodies function when fighting herpes simplex virus infections. “Another important aspect of the work that Matt and Iara have done is that we now have some really good monoclonal antibodies that we’ve made in the lab that could potentially be used directly as a medication to treat acute neonatal herpes infections, which are life-threatening to newborns,” Leib said.